Watch past educational presentations and see live events in real time
Reference our medication guides for helpful information
Explore available award and grant opportunities for fellows-in-training.
Make a choice that matters
The best care starts with the best information. See videos to help answer your questions.
The ACR is accepting applications for mini curriculums, which are educational activities or curriculums to enhance the ACR Core Curriculum Outline.
The ACR Committee on Training and Workforce is pleased to present the Virtual Rheumatology Practicum for Pediatric Rheumatology Fellows (ViP Pediatric). This 8-week lecture series, which launched July 7, 2020, is designed for first-year fellows in training enrolled in pediatric fellowship programs. View the ViP program schedule for the schedule of topics, learning objectives, and materials to read in advance.
Program Schedule, Learning Objectives, and Advance Reading Material - Updated July 31, 2020
Note: You may need to clear your browser's cache to view updated document.
Watch ViP Pediatric Playlist
This program is designed for educational purposes only. The material presented is not intended to represent the only or the best methods appropriate for the medical situations discussed, but rather is intended to present the opinions of the authors or presenters, which may be helpful to other practitioners. Attendees participating in this education activity sponsored by the ACR do so with full knowledge that they waive any claim they may have against the ACR for reliance on any information presented during this educational activity.
Pediatric Scleroderma: Challenging Rare DiseasesSuzanne C. Li, MD, PhD
In this presentation, Suzanne C. Li, MD, PhD, will provide an overview of the similarities and differences between two types of pediatric scleroderma, localized scleroderma, and systemic sclerosis. The diagnosis, clinical features, and major morbidities associated with each type will be reviewed. The general approach to the evaluation and management of patients with pediatric scleroderma will be discussed.
Vasculitis (ANCA, Systemic)Marinka Twilt, MD, MScE, PhD
In this presentation, Marinka Twilt, MD, MScE, PhD, will conduct a case-based discussion about the clinical presentation of childhood ANCA-associated vasculitides. Review the differential diagnosis of pulmonary renal syndrome specifically, and review the current state of evidence for the treatment of childhood AAV.
Introduction to AutoinflammationScott Canna, MD
In this presentation, Scott Canna, MD, will use the evaluation of recurrent fevers as an entrée to the expanding world of autoinflammatory disorders. The lecture will highlight practical tips, red flags, occult symptoms, and real-time resources. However, the underlying premise is that a dynamic understanding of innate immunology is a precondition of understanding and appropriately managing suspected monogenic autoinflammatory disease.
Wolf at the Door: Childhood Onset LupusStacey Ardoin, MD, MS
In this presentation, Stacey Ardoin, MD, MS, will conduct a case-based discussion about the approach to diagnosing and treating childhood-onset SLE. Pathophysiology and long-term outcomes will also be reviewed.
Juvenile DermatomyositisStacey Tarvin, MD, MS, FAAP, FARC
Juvenile dermatomyositis (JDM), the most common chronic childhood rheumatic inflammatory muscle disease, will be discussed in this lecture. In this presentation, Stacey Tarvin, MD, MS, FAAP, FARC, will review the clinical presentation and differential diagnosis of childhood myositis. Classification criteria for idiopathic inflammatory myopathy will be discussed. Treatment approaches, prognosis and disease-related emergencies in JDM will be reviewed.
Systemic Inflammation in Children: Systemic JIA, Macrophage Activation Syndrome, and COVID-associated MIS-CGrant Schulert, MD, PhD
Pediatric rheumatologists frequently evaluate children with unexplained fever and signs of systemic inflammation. In this session, Grant Schulert, MD, PhD, will review the approach to systemic JIA, as well as the related complication macrophage activation syndrome. This session will also review the newly recognized multisystem inflammatory syndrome in children (MIS-C) temporally associated with COVID-19.
Juvenile Idiopathic ArthritisPamela Weiss, MD, MSCE
In this presentation, Pamela Weiss, MD, MSCE, covers the JIA classification schema, major clinical features of each JIA category (except systemic), initial treatment approaches, tools to assess JIA disease activity and outcomes, and an introduction to clinical trial designs for JIA.
Approach to Joint Pain; Reactive/Post-Infectious ConsiderationsT. Brent Graham, MD, MS
This presentation will cover approach to musculoskeletal pain. We will review an approach that will focus on number of joints affected and presence or absence of arthritis to help guide differential based upon categories of disease.
If you have questions about ViP Pediatric, contact Connie Herndon, Director of Research, Training, and Workforce.